Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
暂无分享,去创建一个
L. Ramdas | G. Rassidakis | L. Medeiros | Y. Fujio | R. Lai | A. Goy | H. Amin | K. Kunisada | F. Gilles | L. Medeiros | C. Cutler | Hesham M. Amin
[1] G. Rassidakis,et al. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[3] Fernando U Garcia,et al. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] A. Feller,et al. Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays. , 2002, Journal of hematotherapy & stem cell research.
[5] Zhiheng Yu,et al. STAT1 and STAT3 mediate thrombin-induced expression of TIMP-1 in human glomerular mesangial cells. , 2002, Kidney international.
[6] Rajiv Dhir,et al. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. , 2002, The Journal of urology.
[7] I. Kawase,et al. Cardiac-specific Activation of Signal Transducer and Activator of Transcription 3 Promotes Vascular Formation in the Heart* , 2002, The Journal of Biological Chemistry.
[8] D. Levy,et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death , 2002, Oncogene.
[9] Y. Fujio,et al. Activation of Signal Transducer and Activator of Transcription 3 Protects Cardiomyocytes from Hypoxia/Reoxygenation-Induced Oxidative Stress Through the Upregulation of Manganese Superoxide Dismutase , 2001, Circulation.
[10] Hua Yu,et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.
[11] D. Venzon,et al. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. , 2001, Blood.
[12] Roy Garcia,et al. STATs in oncogenesis , 2000, Oncogene.
[13] Simon C Watkins,et al. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Kossakowska,et al. Matrix Metalloproteinases and Their Tissue Inhibitors - Expression, Role and Regulation in Human Malignant Non-Hodgkin's Lymphomas , 2000, Leukemia & lymphoma.
[15] G. Li,et al. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. , 1999, Cancer research.
[16] Joshua M. Stuart,et al. MICROARRAY EXPERIMENTS : APPLICATION TO SPORULATION TIME SERIES , 1999 .
[17] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[18] H. Nielsen,et al. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer , 1999, British Journal of Cancer.
[19] J. Rhim,et al. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] P. Henriet,et al. Tissue inhibitors of metalloproteinases (TEMP) in invasion and proliferation , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[21] A. Baker,et al. ©1999 Cancer Research Campaign Article no. bjoc.1998.0217 Inhibition of invasion and induction of apoptotic cell , 2022 .
[22] M. Duffy,et al. High levels of tissue inhibitor of metalloproteinase‐1 predict poor outcome in patients with breast cancer , 1999, International journal of cancer.
[23] M. Stetler-Stevenson,et al. Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. , 1998, Blood.
[24] Y. Fujio,et al. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.
[25] D. Wakefield,et al. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes , 1998, European journal of immunology.
[26] P. Rothman,et al. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients. , 1997, Journal of immunology.
[27] J. Darnell. STATs and gene regulation. , 1997, Science.
[28] J. Fata,et al. Altered tumor growth and metastasis of a T-cell lymphoma in Timp-1 transgenic mice. , 1997, Blood.
[29] G. Marti,et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. , 1997, Blood.
[30] J. Dayer,et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.
[31] H. Sato,et al. Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1). , 1994, The Journal of biological chemistry.
[32] T. Sato,et al. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. , 1990, Biochemical and biophysical research communications.
[33] T. Hayakawa. Multiple functions of tissue inhibitors of metalloproteinases (TIMPs): a new aspect involving osteoclastic bone resorption , 2002, Journal of Bone and Mineral Metabolism.
[34] V. Diehl,et al. Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells. , 2002, Blood.
[35] T. Grogan,et al. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. , 1999, Blood.
[36] A. Kugler. Matrix metalloproteinases and their inhibitors. , 1999, Anticancer research.
[37] B. Groner,et al. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. , 1996, Blood.
[38] P. Heinrich,et al. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. , 1995, Nucleic acids research.
[39] A. Kossakowska,et al. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. , 1992, Oncology research.